Steven Boyd, Director, 10% Owner at EYEGATE PHARMACEUTICALS INC (EYEG), sold 5,906,276 shares at $3.28 ($27.9M) on 2021-07-28, disclosed to the SEC on 2021-07-29.
Open-market sale of $27.9M EYEG by Director, 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.80 | 581,614 | $2.2M | 7.9% |
| 2 | $3.80 | 581,614 | $2.2M | 7.9% |
| 3 | $4.59 | 532,069 | $2.4M | 8.8% |
| 4 | $4.59 | 532,069 | $2.4M | 8.8% |
| 5 | $5.44 | 729,114 | $4.0M | 14.2% |
| 6 | $5.44 | 729,114 |
| $4.0M |
| 14.2% |
| 7 | $6.45 | 461,797 | $3.0M | 10.7% |
| 8 | $6.45 | 461,797 | $3.0M | 10.7% |
| 9 | $7.06 | 73,101 | $516K | 1.9% |
| 10 | $7.06 | 73,101 | $516K | 1.9% |
| 11 | $3.28 | 375,443 | $1.2M | 4.4% |
| 12 | $3.28 | 375,443 | $1.2M | 4.4% |
| 13 | $3.00 | 400,000 | $1.2M | 4.3% |
| Total | $4.72 avg | 5,906,276 | $27.9M | 100% |
| Filing → |
| AVTX | BUY | 2022-01-14 | $451K | — | Filing → |
| CERC | BUY | 2021-08-18 | $194K | — | Filing → |
| RSLS | SELL | 2021-06-22 | $28.5M | — | Filing → |